(NASDAQ: NUWE) Nuwellis's forecast annual revenue growth rate of 35.03% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.68%.
Nuwellis's revenue in 2025 is $8,787,000.On average, 1 Wall Street analysts forecast NUWE's revenue for 2025 to be $39,934,328, with the lowest NUWE revenue forecast at $39,934,328, and the highest NUWE revenue forecast at $39,934,328. On average, 1 Wall Street analysts forecast NUWE's revenue for 2026 to be $60,535,717, with the lowest NUWE revenue forecast at $60,535,717, and the highest NUWE revenue forecast at $60,535,717.
In 2027, NUWE is forecast to generate $97,320,788 in revenue, with the lowest revenue forecast at $97,320,788 and the highest revenue forecast at $97,320,788.